Today: 21 July 2026
Browse Category

NYSE:JNJ 10 January 2026 - 19 January 2026

For live price, interactive charts, financials and the latest market data, visit Google Finance.
Dow Jones futures drop on Trump tariff threat as Wall Street sets up for Netflix, PCE week

Dow Jones futures drop on Trump tariff threat as Wall Street sets up for Netflix, PCE week

Dow Jones futures slipped roughly 0.7% Monday following President Donald Trump's threat to impose an additional 10% tariff on imports from eight European nations tied to Greenland. Stephen Innes from SPI Asset Management commented, “This is not a short-term liquidation story. It is a slow rebalancing story, and those are far more consequential.”
19 January 2026
·····
Trump’s Greenland tariff threat sets up a tense week for global stocks

Trump’s Greenland tariff threat sets up a tense week for global stocks

Global stock markets are bracing for volatility this week after President Donald Trump threatened new tariffs on eight European countries if the U.S. isn’t allowed to buy Greenland. He announced a 10% import tariff starting Feb. 1, set to jump to 25% on June 1 unless a deal is struck. The tariffs would hit Denmark, Norway, Sweden, France, Germany, the Netherlands, Finland, and Britain.
18 January 2026
···
Healthcare stocks slide into long weekend as XLV drops; J&J earnings loom

Healthcare stocks slide into long weekend as XLV drops; J&J earnings loom

U.S. healthcare stocks wrapped up the week as the S&P 500’s weakest sector, with the Health Care Select Sector SPDR Fund slipping 0.8% on Friday to $155.74. Anthony Saglimbene, chief market strategist at Ameriprise Financial, noted that “most investors will take that as a win,” given the market hovered near record highs despite a volatile week.
17 January 2026
······
Johnson & Johnson stock pops on court win — what traders watch before earnings

Johnson & Johnson stock pops on court win — what traders watch before earnings

Johnson & Johnson shares climbed about 1.9%, closing at $213.65 on Tuesday, and stayed near that level in after-hours trading after Delaware’s highest court pared down part of a $1 billion damages award related to its Auris Health acquisition. The Delaware Supreme Court ordered a recalculation that could shave a few hundred million dollars, including interest, off the total. This dispute traces back to J&J’s 2019 purchase of surgical-robot maker Auris and the earnout payments tied to performance milestones owed to former shareholders. “We are pleased that the court reversed the trial court’s improper substitution,” J&J said.
14 January 2026
··
Johnson & Johnson stock jumps as Delaware court pares Auris damages hit, earnings next week

Johnson & Johnson stock jumps as Delaware court pares Auris damages hit, earnings next week

Johnson & Johnson shares climbed roughly 1.6% to $212.98 on Tuesday, bucking a minor slide in healthcare stocks as the overall market showed little direction. The stock hit a session peak of $213.48 and dipped to $208.93 at its low. Meanwhile, the Health Care Select Sector SPDR ETF fell around 0.3%, with the S&P 500 ETF holding steady.
13 January 2026
···
Johnson & Johnson stock in focus: Trump drug-price pact and fresh cancer data before Monday

Johnson & Johnson stock in focus: Trump drug-price pact and fresh cancer data before Monday

Shares of Johnson & Johnson dipped 0.7% on Friday to $204.39 following the company's announcement of a deal with the Trump administration to lower U.S. drug prices. In return, J&J secured exemptions from certain U.S. tariffs. The company said it will offer medicines at discounted rates via TrumpRx.gov and match Medicaid pricing levels seen in other developed countries, though it did not specify which drugs would be involved or the exact discount sizes. The administration made similar deals with nine other pharmaceutical firms in December as part of its effort to close the gap that leaves U.S. patients paying nearly three times more than those abroad.
11 January 2026
··
1 2 3 4 5 6 … 9
Go toTop